At a glance
ClinicalIndex Comparison RecordN/ACompleted· 416 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pramipexole Special Survey on Patients Without Concomitant Use of L-Dopa
In Brief
An observational study for Parkinson Disease. Completed, enrolled 416 participants across 119 sites.
Detailed Summary
The survey is conducted to collect safety and effectiveness information in Parkinson's Disease patients treated with Pramipexole without concomitant L-Dopa supplementation in the daily clinical settings in Japan.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2004
First PostedFeb 2008
Primary CompletionSep 2009
TodayJul 2026
First PostedFeb 13, 2008
Enrollment StartFeb 1, 2004
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 18.4 years ago